Cel Sci Corp Stock Current Valuation
| CVM Stock | USD 0.60 0.10 14.29% |
Valuation analysis of CEL SCI Corp helps investors to measure CEL SCI's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. As of the 28th of December 2024, Enterprise Value is likely to grow to about 82.9 M, while Enterprise Value Over EBITDA is likely to drop (2.23). Fundamental drivers impacting CEL SCI's valuation include:
Price Book 4.5191 | Enterprise Value 50 M | Enterprise Value Ebitda (3.71) | Price Sales 11.8 K |
Undervalued
Today
Please note that CEL SCI's price fluctuation is dangerous at this time. Calculation of the real value of CEL SCI Corp is based on 3 months time horizon. Increasing CEL SCI's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the CEL stock is determined by what a typical buyer is willing to pay for full or partial control of CEL SCI Corp. Since CEL SCI is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CEL Stock. However, CEL SCI's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.6 | Real 2.57 | Target 8.5 | Hype 0.55 |
The intrinsic value of CEL SCI's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence CEL SCI's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of CEL SCI Corp helps investors to forecast how CEL stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CEL SCI more accurately as focusing exclusively on CEL SCI's fundamentals will not take into account other important factors: CEL SCI Corp Company Current Valuation Analysis
CEL SCI's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current CEL SCI Current Valuation | 50.04 M |
Most of CEL SCI's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CEL SCI Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
CEL Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for CEL SCI is extremely important. It helps to project a fair market value of CEL Stock properly, considering its historical fundamentals such as Current Valuation. Since CEL SCI's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of CEL SCI's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of CEL SCI's interrelated accounts and indicators.
Click cells to compare fundamentals
CEL Current Valuation Historical Pattern
Today, most investors in CEL SCI Stock are looking for potential investment opportunities by analyzing not only static indicators but also various CEL SCI's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of CEL SCI current valuation as a starting point in their analysis.
CEL SCI Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, CEL SCI Corp has a Current Valuation of 50.04 M. This is 99.65% lower than that of the Biotechnology sector and 98.92% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.7% higher than that of the company.
CEL Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CEL SCI's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CEL SCI could also be used in its relative valuation, which is a method of valuing CEL SCI by comparing valuation metrics of similar companies.CEL SCI is currently under evaluation in current valuation category among its peers.
CEL SCI Current Valuation Drivers
We derive many important indicators used in calculating different scores of CEL SCI from analyzing CEL SCI's financial statements. These drivers represent accounts that assess CEL SCI's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of CEL SCI's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 468.7M | 446.9M | 133.3M | 55.6M | 50.0M | 83.9M | |
| Enterprise Value | 467.1M | 426.8M | 126.0M | 65.0M | 58.5M | 82.9M |
CEL Fundamentals
| Return On Equity | -2.5 | ||||
| Return On Asset | -0.61 | ||||
| Current Valuation | 50.04 M | ||||
| Shares Outstanding | 63.81 M | ||||
| Shares Owned By Insiders | 2.91 % | ||||
| Shares Owned By Institutions | 10.46 % | ||||
| Number Of Shares Shorted | 4.43 M | ||||
| Price To Earning | (1.14) X | ||||
| Price To Book | 4.52 X | ||||
| Price To Sales | 11,797 X | ||||
| Gross Profit | (25.36 M) | ||||
| EBITDA | (27.56 M) | ||||
| Net Income | (32.19 M) | ||||
| Cash And Equivalents | 22.67 M | ||||
| Cash Per Share | 0.65 X | ||||
| Total Debt | 13.57 M | ||||
| Debt To Equity | 0.41 % | ||||
| Current Ratio | 7.71 X | ||||
| Book Value Per Share | 0.16 X | ||||
| Cash Flow From Operations | (22.85 M) | ||||
| Short Ratio | 18.05 X | ||||
| Earnings Per Share | (0.52) X | ||||
| Target Price | 7.73 | ||||
| Beta | 0.69 | ||||
| Market Capitalization | 44.71 M | ||||
| Total Asset | 30.53 M | ||||
| Retained Earnings | (487.09 M) | ||||
| Working Capital | 1.33 M | ||||
| Current Asset | 5.89 M | ||||
| Current Liabilities | 4.01 M | ||||
| Net Asset | 30.53 M |
About CEL SCI Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CEL SCI Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CEL SCI using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CEL SCI Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out CEL SCI Piotroski F Score and CEL SCI Altman Z Score analysis. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CEL SCI. If investors know CEL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CEL SCI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.52) | Revenue Per Share 0.001 | Quarterly Revenue Growth (0.63) | Return On Assets (0.61) | Return On Equity (2.50) |
The market value of CEL SCI Corp is measured differently than its book value, which is the value of CEL that is recorded on the company's balance sheet. Investors also form their own opinion of CEL SCI's value that differs from its market value or its book value, called intrinsic value, which is CEL SCI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CEL SCI's market value can be influenced by many factors that don't directly affect CEL SCI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CEL SCI's value and its price as these two are different measures arrived at by different means. Investors typically determine if CEL SCI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CEL SCI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.